LifeStance Reports Strong Third Quarter 2026 Financial Results and Raises Full Year Outlook

LifeStance Health Group announced Q3 2026 financial results with revenue of $455.9 million, up 25% year-over-year, and net income of $22.4 million compared to $1.1 million in Q3 2025. The company raised its full-year 2026 guidance across all metrics, including revenue to $1.741-$1.761 billion and Adjusted EBITDA to $242-$250 million. The clinician base grew 11% to 8,863, and visit volumes increased 17% to 2.7 million.